ProCE Banner Activity

Prognostic and Predictive Measures of Therapeutic Benefit in Early Breast Cancer

Slideset Download
Learn how experts leverage the latest data and clinical tools to estimate prognosis and predict treatment benefit in patients with HR-positive, HER2-negative early breast cancer.

Released: June 15, 2021

Expiration: June 14, 2022

No longer available for credit.

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Lilly